XGN

Exagen Stock Analysis

AI Rating

Fair
  • Quality0/10
  • Growth 4/10
  • Value 1/10
Exagen sales and earnings growth
XGN Growth
Neutral
  • Revenue Y/Y 20.55%
  • EPS Y/Y -5.95%
  • FCF Y/Y 8.60%
Exagen gross and profit margin trends
XGN Profitability
Neutral
  • Gross margin 58.30%
  • EPS margin -29.50%
  • ROIC 5Y -43.19%
Exagen net debt vs free cash flow
XGN Risk
Good
  • Debt / Equity 1.9
  • Debt / FCF 0.4
  • Interest coverage -3.0

Exagen stock volatility is in-line with the overall market. We give it a Good risk rating.

↗ More Diagnostics & Research stocks